OKYO Pharma Ltd (NASDAQ:OKYO), a clinical-stage biopharmaceutical company developing therapies for neuropathic corneal pain (NCP) and inflammatory eye diseases, announced that its abstract has been ...

As universities increasingly adopt digital tools and automated analytics systems, attention often centers on these tools' ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 1 of the Bionano Symposium 2026 entitled Advancements in Hematologic Malignancies with Optical Genome Mapping (OGM).

OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the ...

Artificial intelligence is profoundly reshaping the design paradigm of sportswear, driving the industry’s transition from traditional experience-driven methods to a digital model characterized by data ...

Being invited to present research at an international academic conference is an honor for any seasoned professional. But for ...

The book discusses how planners can effectively use AI in their daily practices, engage constructively with technical ...

Beyond sharing data, DQS aligns multiple data sources, including sponsors’ clinical trial management system data, public registries, and clinical trial databases, to provide a single, holistic, and ...

UNR Med’s IDEA Project uses AI and hands-on data analysis to teach first-year medical students how to think like clinical researchers.

OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic ...

The meeting will feature sessions on AI in heart failure, advanced LVAD technologies, cardiac xenotransplantation, and more.

At SCOPE Summit 2026, site leaders shared how AI is transforming feasibility, patient identification, and enrollment strategies, enabling research sites to boost performance, strengthen sponsor ...